Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.53−0.71 (-6.93%)
Close on Nov 13, 2026Market cap $554.07MP/E –Yield –
Capricor Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Capricor Therapeutics's total assets was $330.37M at Sep 30, 2026. For fiscal 2025 it was $355.95M, up 108.8% from the year before. Over ten years it grew 36.3% a year on average. The highest annual figure on record is $355.95M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $355.95M | +108.8% |
| FY2024 | Dec 31, 2024 | $170.48M | +190.3% |
| FY2023 | Dec 31, 2023 | $58.73M | +17.2% |
| FY2022 | Dec 31, 2022 | $50.09M | +21.2% |
| FY2021 | Dec 31, 2021 | $41.33M | +19.4% |
| FY2020 | Dec 31, 2020 | $34.62M | +211.5% |
| FY2019 | Dec 31, 2019 | $11.11M | +20.2% |
| FY2018 | Dec 31, 2018 | $9.25M | -43.2% |
| FY2017 | Dec 31, 2017 | $16.27M | -13.2% |
| FY2016 | Dec 31, 2016 | $18.75M | +16.7% |
| FY2015 | Dec 31, 2015 | $16.07M | +17.9% |
| FY2014 | Dec 31, 2014 | $13.63M | +146.2% |
| FY2013 | Dec 31, 2013 | $5.54M | +2.1% |
| FY2012 | Dec 31, 2012 | $5.42M | +295.3% |
| FY2011 | Dec 31, 2011 | $1.37M | -62.6% |
| FY2010 | Dec 31, 2010 | $3.67M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $330.37M | +161.3% |
| Q2 FY2026 | Jun 30, 2026 | $368.74M | +176.1% |
| Q1 FY2026 | Mar 31, 2026 | $326.28M | +112.2% |
| Q4 FY2025 | Dec 31, 2025 | $355.95M | +108.8% |
| Q3 FY2025 | Sep 30, 2025 | $126.44M | +36.0% |
| Q2 FY2025 | Jun 30, 2025 | $133.57M | +248.9% |
| Q1 FY2025 | Mar 31, 2025 | $153.77M | +211.0% |
| Q4 FY2024 | Dec 31, 2024 | $170.48M | +190.3% |
| Q3 FY2024 | Sep 30, 2024 | $92.95M | +150.2% |
| Q2 FY2024 | Jun 30, 2024 | $38.28M | -16.8% |
| Q1 FY2024 | Mar 31, 2024 | $49.44M | -8.2% |
| Q4 FY2023 | Dec 31, 2023 | $58.73M | +17.2% |
| Q3 FY2023 | Sep 30, 2023 | $37.15M | -31.1% |
| Q2 FY2023 | Jun 30, 2023 | $46.01M | -20.8% |
| Q1 FY2023 | Mar 31, 2023 | $53.86M | -17.0% |
| Q4 FY2022 | Dec 31, 2022 | $50.09M | +21.2% |
| Q3 FY2022 | Sep 30, 2022 | $53.93M | +25.1% |
| Q2 FY2022 | Jun 30, 2022 | $58.07M | +45.4% |
| Q1 FY2022 | Mar 31, 2022 | $64.92M | +49.1% |
| Q4 FY2021 | Dec 31, 2021 | $41.33M | +19.4% |
| Q3 FY2021 | Sep 30, 2021 | $43.10M | +19.1% |
| Q2 FY2021 | Jun 30, 2021 | $39.93M | +7.6% |
| Q1 FY2021 | Mar 31, 2021 | $43.54M | +204.6% |
| Q4 FY2020 | Dec 31, 2020 | $34.62M | +211.5% |
| Q3 FY2020 | Sep 30, 2020 | $36.19M | +357.6% |
| Q2 FY2020 | Jun 30, 2020 | $37.13M | +408.1% |
| Q1 FY2020 | Mar 31, 2020 | $14.29M | +65.9% |
| Q4 FY2019 | Dec 31, 2019 | $11.11M | +20.2% |
| Q3 FY2019 | Sep 30, 2019 | $7.91M | -35.4% |
| Q2 FY2019 | Jun 30, 2019 | $7.31M | -49.0% |
| Q1 FY2019 | Mar 31, 2019 | $8.62M | -44.0% |
| Q4 FY2018 | Dec 31, 2018 | $9.25M | -43.2% |
| Q3 FY2018 | Sep 30, 2018 | $12.23M | -22.5% |
| Q2 FY2018 | Jun 30, 2018 | $14.33M | +0.8% |
| Q1 FY2018 | Mar 31, 2018 | $15.39M | +9.4% |
| Q4 FY2017 | Dec 31, 2017 | $16.27M | -13.2% |
| Q3 FY2017 | Sep 30, 2017 | $15.79M | – |
| Q2 FY2017 | Jun 30, 2017 | $14.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $14.07M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.75M | – |
See a number that looks wrong?